No Data
No Data
Simpluris Announces Proposed Settlement Involving Purchasers of Ampio Pharmaceuticals, Inc.'s ("Ampio") Common Stock
Ampio Pharmaceuticals Received Audit Opinion With Going Concern Explanation
Express News | Ampio Pharmaceuticals Q4 EPS $(2.48) Up From $(3.60) YoY
Top Midday Decliners
VERI, CHEK and CZOO Among Mid-day Movers
NYSE American New 52-Week Highs And Lows
No Data